Oculomotor Disorders

ABSTRACT

Ocular misalignment and nystagmus result in the visual symptoms of binocular diplopia and oscillopsia, and are frequently encountered in neurological practice. Correct localization of the underlying problem is the first step to accurate diagnosis, and requires a systematic approach and knowledge of the ocular motor pathways and actions of the extraocular muscles. This article contains three segments: The first outlines the diagnostic approach with attention to fine historical and examination details helpful in localization; the second describes common localizations of diplopia including extraocular muscle, neuromuscular junction, cranial nerve and nuclei, and supranuclear structures with attention to examination features characteristic for each location; and the third describes the types of acquired nystagmus and their treatments.

KEYWORDS

Eye movements - binocular diplopia - oscillopsia - nystagmus

REFERENCES

• 1 Carpenter R. The visual origins of ocular motility. In: Carpenter R Eye Movements. London; MacMillan Press 1991: 1-10
• 2 Coffeen P, Guyton D L. Monocular diplopia accompanying ordinary refractive errors.  Am J Ophthalmol. 1988;  105 451-459
• 3 Barton J J. “Retinal diplopia” associated with macular wrinkling.  Neurology. 2004;  63 925-927
• 4 De Pool M E, Campbell J P, Broome S O, Guyton D L. The dragged-fovea diplopia syndrome: clinical characteristics, diagnosis, and treatment.  Ophthalmology. 2005;  112 1455-1462
• 5 Rucker J C, Tomsak R L. Binocular diplopia: a practical approach.  Neurologist. 2005;  11 98-110
• 6 Cremer P D, Halmagyi G M, Aw S T et al.. Semicircular canal plane head impulses detect absent function of individual semicircular canals.  Brain. 1998;  121 699-716
• 7 Black R A, Halmagyi G M, Thurtell M J, Todd M J, Curthoys I S. The active head-impulse test in unilateral peripheral vestibulopathy.  Arch Neurol. 2005;  62 290-293
• 8 Toth C, McDonald D, Oger J, Brownell K. Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease.  Acta Neurol Scand. 2006;  114 124-132
• 9 Marino M, Barbesino G, Pinchera A et al.. Increased frequency of euthyroid ophthalmopathy in patients with Graves' disease associated with myasthenia gravis.  Thyroid. 2000;  10 799-802
• 10 Nicholson G A, McLeod J G, Griffiths L R. Comparison of diagnostic tests in myasthenia gravis.  Clin Exp Neurol. 1983;  19 45-49
• 11 Beekman R, Kuks J B, Oosterhuis H J. Myasthenia gravis: diagnosis and follow-up of 100 consecutive patients.  J Neurol. 1997;  244 112-118
• 12 Ing E B, Ing S Y, Ing T, Ramocki J A. The complication rate of edrophonium testing for suspected myasthenia gravis.  Can J Ophthalmol. 2000;  35 141-144 , discussion 145
• 13 Kupersmith M J, Latkany R, Homel P. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.  Arch Neurol. 2003;  60 243-248
• 14 Ellis F D, Hoyt C S, Ellis F J, Jeffery A R, Sondhi N. Extraocular muscle responses to orbital cooling (ice test) for ocular myasthenia gravis diagnosis.  J AAPOS. 2000;  4 271-281
• 15 Benatar M. A systematic review of diagnostic studies in myasthenia gravis.  Neuromuscul Disord. 2006;  16 459-467
• 16 Odel J G, Winterkorn J M, Behrens M M. The sleep test for myasthenia gravis: a safe alternative to Tensilon.  J Clin Neuroophthalmol. 1991;  11 288-292
• 17 Costa J, Evangelista T, Conceicao I, de Carvalho M. Repetitive nerve stimulation in myasthenia gravis: relative sensitivity of different muscles.  Clin Neurophysiol. 2004;  115 2776-2782
• 18 Padua L, Stalberg E, LoMonaco M, Evoli A, Batocchi A, Tonali P. SFEMG in ocular myasthenia gravis diagnosis.  Clin Neurophysiol. 2000;  111 1203-1207
• 19 Bennett D L, Mills K R, Riordan-Eva P, Barnes P R, Rose M R. Anti-MuSK antibodies in a case of ocular myasthenia gravis.  J Neurol Neurosurg Psychiatry. 2006;  77 564-565
• 20 Hanisch F, Eger K, Zierz S. MuSK-antibody positive pure ocular myasthenia gravis.  J Neurol. 2006;  253 659-660
• 21 Kupersmith M J, Ying G. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.  Br J Ophthalmol. 2005;  89 1330-1334
• 22 Carrasco J R, Savino P J, Bilyk J R. Primary aberrant oculomotor nerve regeneration from a posterior communicating artery aneurysm.  Arch Ophthalmol. 2002;  120 663-665
• 23 Keane J R. Bilateral involvement of a single cranial nerve: analysis of 578 cases.  Neurology. 2005;  65 950-952
• 24 Feinberg A S, Newman N J. Schwannoma in patients with isolated unilateral trochlear nerve palsy.  Am J Ophthalmol. 1999;  127 183-188
• 25 Hanson R A, Ghosh S, Gonzalez-Gomez I, Levy M L, Gilles F H. Abducens length and vulnerability?.  Neurology. 2004;  62 33-36
• 26 Dhaliwal A, West A L, Trobe J D, Musch D C. Third, fourth, and sixth cranial nerve palsies following closed head injury.  J Neuroophthalmol. 2006;  26 4-10
• 27 Rabadi M H, Beltmann M A. Midbrain infarction presenting isolated medial rectus nuclear palsy.  Am J Med. 2005;  118 836-837
• 28 Kwon J H, Kwon S U, Ahn H S, Sung K B, Kim J S. Isolated superior rectus palsy due to contralateral midbrain infarction.  Arch Neurol. 2003;  60 1633-1635
• 29 Miller N R, Biousse V, Hwang T, Patel S, Newman N J, Zee D S. Isolated acquired unilateral horizontal gaze paresis from a putative lesion of the abducens nucleus.  J Neuroophthalmol. 2002;  22 204-207
• 30 Gamlin P D, Gnadt J W, Mays L E. Lidocaine-induced unilateral internuclear ophthalmoplegia: effects on convergence and conjugate eye movements.  J Neurophysiol. 1989;  62 82-95
• 31 Frohman T C, Frohman E M, O'Suilleabhain P et al.. Accuracy of clinical detection of INO in MS: corroboration with quantitative infrared oculography.  Neurology. 2003;  61 848-850
• 32 Kim J S. Internuclear ophthalmoplegia as an isolated or predominant symptom of brainstem infarction.  Neurology. 2004;  62 1491-1496
• 33 Choi K D, Jung D S, Kim J S. Specificity of “peering at the tip of the nose” for a diagnosis of thalamic hemorrhage.  Arch Neurol. 2004;  61 417-422
• 34 Messe S R, Cucchiara B L. Wrong-way eyes with thalamic hemorrhage.  Neurology. 2003;  60 1524
• 35 Leigh R J, Thurston S E, Tomsak R L, Grossman G E, Lanska D J. Effect of monocular visual loss upon stability of gaze.  Invest Ophthalmol Vis Sci. 1989;  30 288-292
• 36 Averbuch-Heller L, Tusa R J, Fuhry L et al.. A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus.  Ann Neurol. 1997;  41 818-825
• 37 Shery T, Proudlock F A, Sarvananthan N, McLean R J, Gottlob I. The effects of gabapentin and memantine in acquired and congenital nystagmus: a retrospective study.  Br J Ophthalmol. 2006;  90 839-843
• 38 Halmagyi G M, Leigh R J. Upbeat about downbeat nystagmus.  Neurology. 2004;  63 606-607
• 39 Strupp M, Schuler O, Krafczyk S et al.. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.  Neurology. 2003;  61 165-170
• 40 Kalla R, Glasauer S, Schautzer F et al.. 4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain.  Neurology. 2004;  62 1228-1229
• 41 Cohen B, Helwig D, Raphan T. Baclofen and velocity storage: a model of the effects of the drug on the vestibulo-ocular reflex in the rhesus monkey.  J Physiol. 1987;  393 703-725
• 42 Zee D S, Robinson D A. A hypothetical explanation of saccadic oscillations.  Ann Neurol. 1979;  5 405-414
• 43 Kaneko C R. Effect of ibotenic acid lesions of the omnipause neurons on saccadic eye movements in rhesus macaques.  J Neurophysiol. 1996;  75 2229-2242